JPMORGAN CHASE & CO

Position in ATNM — Actinium Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in ATNM

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,486

-$545 QoQ

Shares Held

1,494

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ATNM ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	24,150,499	$3,949,089,591
2	REGN	Regeneron Pharmaceuticals, Inc.	4,311,806	$3,331,473,778
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,033,156	$3,140,585,469
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,323,752	$2,092,339,815
5	NUVL	Nuvalent, Inc.	3,088,349	$316,401,351
6	JAZZ	Jazz Pharmaceuticals plc	1,204,353	$227,682,931
7	IONS	Ionis Pharmaceuticals Inc	2,363,567	$177,480,242
8	TERN	Terns Pharmaceuticals, Inc.	2,869,728	$151,292,056

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,486	1,494	0.0%	Shares	Defined	2026-05-13
2025-12-31	$2,031	1,494	-4.4%	Shares	Defined	2026-02-11
2025-09-30	$2,498	1,562	-91.6%	Shares	Defined	2025-11-26
2025-06-30	$26,063	18,617	-11.9%	Shares	Defined	2025-08-12
2025-03-31	$34,008	21,124	-82.9%	Shares	Defined	2025-05-12
2024-12-31	$156,026	123,831	+804.5%	Shares	Defined	2025-02-12
2024-09-30	$25,736	13,690	-1.5%	Shares	Defined	2024-12-26
2024-06-30	$102,821	13,895	+17.9%	Shares	Defined	2024-12-26
2024-03-31	$92,267	11,784	-36.5%	Shares	Defined	2024-12-26
2023-12-31	$94,345	18,572	+2.5%	Shares	Defined	2024-12-26
2023-09-30	$107,270	18,120	-10.2%	Shares	Defined	2023-11-14
2023-06-30	$149,646	20,168	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.